Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-18, Stock:PFE, The news for the past five days is as follows:
2019-06-11: NEWS1: Health Care Sector Update for 06/11/2019: CBAY, MOTS, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS2: Health Care Sector Update for 06/11/2019: CBAY, MOTS, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS3: See what the IHS Markit Score report has to say about Pfizer Inc..
2019-06-12: NEWS1: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS2: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS3: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS4: Top Ranked Income Stocks to Buy for June 12th.NEWS5: Top Ranked Income Stocks to Buy for June 12th.NEWS6: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS7: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS8: Top Ranked Income Stocks to Buy for June 12th.NEWS9: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS10: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS11: Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS14: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS15: Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor.
2019-06-13: NEWS1: Stocks Bounce Back Amid U.S.-Iran Tanker Tensions.NEWS2: Stocks Bounce Back Amid U.S.-Iran Tanker Tensions.NEWS3: Market Close Report: NASDAQ Composite index closes at 7,837.13 up 44.41 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,837.13 up 44.41 points.NEWS5: J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB.NEWS6: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS7: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS8: Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019.NEWS11: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019.NEWS12: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS13: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS14: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS15: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS16: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS17: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS18: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS19: Pfizer (PFE) Gains As Market Dips: What You Should Know.
2019-06-14: NEWS1: Dow Movers: INTC, UTX.NEWS2: Dow Movers: INTC, UTX.NEWS3: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.NEWS4: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.NEWS5: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS6: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS7: Merck Plans Its First Investor Day in 5 Years. Here’s What to Watch..NEWS8: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS9: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.
2019-06-17: NEWS1: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS2: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS3: What Happened in the Stock Market Today.NEWS4: What Happened in the Stock Market Today.NEWS5: What Happened in the Stock Market Today.NEWS6: Why Pfizer&apos;s Acquisition of Array BioPharma Won&apos;t Pay Off Anytime Soon.NEWS7: After Hours Most Active for Jun 17, 2019 :  VEON, TRUE, CZR, FDC, KR, LC, LXP, PFE, AEG, MSFT, QCOM, INTC.NEWS8: After Hours Most Active for Jun 17, 2019 :  VEON, TRUE, CZR, FDC, KR, LC, LXP, PFE, AEG, MSFT, QCOM, INTC.NEWS9: How Pfizer&apos;s $11.4 Billion Takeover Of Array Signals More Mergers.NEWS10: Dow Jones Today: Almost a Case of the Mondays.NEWS11: Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal.NEWS12: Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal.NEWS13: Health Care Sector Update for 06/17/2019: VYGR,SNY,BPMC,ARRY,PFE,VBIV.NEWS14: Health Care Sector Update for 06/17/2019: VYGR,SNY,BPMC,ARRY,PFE,VBIV.NEWS15: Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting.NEWS16: Pfizer acquires Array in 2nd major Boulder bioscience merger this month.NEWS17: US STOCKS-Faith in the Fed nudges Wall Street higher.NEWS18: Stocks close higher as social media, real estate shares lead.NEWS19: 5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA.NEWS20: Stocks Rise Modestly in Cautious Trading Ahead of Federal Reserve Meeting.NEWS21: Pfizer Is Buying Array BioPharma, Seeking to Broaden Lineup of Cancer Drugs.NEWS22: Pfizer Is the Latest Drug Company to Put Its Credit Rating at Risk With M&A.NEWS23: The 5 Worst Dow Jones Stocks So Far in 2019.NEWS24: US STOCKS-Faith in the Fed pushes Wall Street higher.NEWS25: Health Care Sector Update for 06/17/2019: BPMC,ARRY,PFE,VBIV.NEWS26: Health Care Sector Update for 06/17/2019: BPMC,ARRY,PFE,VBIV.NEWS27: Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide.NEWS28: Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide.NEWS29: Why Pfizer Is Falling and Array Is Rising on Acquisition News.NEWS30: Stock Market News: Sotheby's, Array Get Winning Bids on a Big Deal Day.NEWS31: Stock Market News: Sotheby's, Array Get Winning Bids on a Big Deal Day.NEWS32: US STOCKS-Wall Street holds on to gains; Fed policy meeting eyed.NEWS33: Pfizer Inc. -- Moody's: Pfizer's acquisition of Array is credit negative.NEWS34: &quot;Merger Monday&quot; Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?.NEWS35: &quot;Merger Monday&quot; Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?.NEWS36: Big Ticket Mergers Are in Focus.NEWS37: Big Ticket Mergers Are in Focus.NEWS38: SPDR S&P 500 ETF Experiences Big Inflow.NEWS39: SPDR S&P 500 ETF Experiences Big Inflow.NEWS40: Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal.NEWS41: US STOCKS-Wall Street moves higher; Fed policy meeting eyed.NEWS42: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to Shareholders.NEWS43: Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist.NEWS44: Why Array BioPharma Stock Is on Fire Today.NEWS45: Big Ticket Mergers Are in Focus.NEWS46: ARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout.NEWS47: &quot;Merger Monday&quot; Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?.NEWS48: US STOCKS-Wall Street moves higher; Fed policy meeting on the horizon.NEWS49: Stocks Mixed in Cautious Trading Ahead of Fed Meeting.NEWS50: Pfizer Expands in Cancer With $10.6 Billion Deal for Array.NEWS51: Stocks mixed as Fed meeting comes into view.NEWS52: Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth.NEWS53: Pfizer buys cancer treatment innovator Array BioPharma for $11 billion.NEWS54: US STOCKS-Wall St set for muted open; Fed meet in focus.NEWS55: S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal.NEWS56: U.S. stocks set to rise cautiously as Federal Reserve gathering comes into focus.NEWS57: Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma.NEWS58: Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma.NEWS59: Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer.NEWS60: Pfizer to buy Array for $10.64 bln.NEWS61: Pfizer to Acquire Array BioPharma.NEWS62: Stocks - Wall Street Mixed as Fed Meeting in Focus.NEWS63: Stocks - Pfizer, Target Fall Premarket; Deutsche Bank, Boeing Rise.

Answer: Rise